Compare KD & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KD | ITGR |
|---|---|---|
| Founded | 2020 | 1970 |
| Country | United States | United States |
| Employees | 80000 | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2021 | 2000 |
| Metric | KD | ITGR |
|---|---|---|
| Price | $13.13 | $87.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $31.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 3.0M | 685.1K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 170.95 | N/A |
| EPS | 0.77 | ★ 2.89 |
| Revenue | ★ $15,057,000,000.00 | $1,853,637,000.00 |
| Revenue This Year | $3.96 | $1.69 |
| Revenue Next Year | $0.41 | $6.53 |
| P/E Ratio | ★ $16.29 | $29.48 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $10.10 | $62.00 |
| 52 Week High | $43.74 | $127.56 |
| Indicator | KD | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 58.23 |
| Support Level | $12.07 | $82.58 |
| Resistance Level | $13.81 | $88.36 |
| Average True Range (ATR) | 0.51 | 2.77 |
| MACD | 0.31 | 0.20 |
| Stochastic Oscillator | 87.77 | 74.16 |
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.